KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19603018

Br. J. Cancer 2009 Aug 18 101 4 715-21

Download in:

View as

Triples

General Info

PMID
19603018